{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:33:08Z","timestamp":1777480388827,"version":"3.51.4"},"reference-count":132,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2022,2,14]]},"abstract":"<jats:p>Ovarian cancer comprises the most lethal gynecologic malignancy and is accompanied by the high potential for the incidence of metastasis, recurrence and chemotherapy resistance, often associated with a formation of ascitic fluid. The differentially expressed ascites-derived microRNAs may be linked to ovarian carcinogenesis. The article focuses on a number of miRNAs that share a common expression pattern as determined by independent studies using ascites samples and with regard to their functions and outcomes in experimental and clinical investigations. Let-7b and miR-143 have featured as tumor suppressors in ovarian cancer, which is in line with data on other types of cancer. Although two miRNAs, i.e. miR-26a-5p and miR-145-5p, act principally as tumor suppressor miRNAs, they occasionally exhibit oncogenic roles. The performance of miR-95-3p, upregulated in ascites, is open to debate given the current lack of supportive data on ovarian cancer; however, data on other cancers indicates its probable oncogenic role. Different findings have been reported for miR-182-5p and miR-200c-3p; in addition to their presumed oncogenic roles, contrasting findings have indicated their ambivalent functions. Further research is required for the identification and evaluation of the potential of specific miRNAs in the diagnosis, prediction, treatment and outcomes of ovarian cancer patients.<\/jats:p>","DOI":"10.3233\/cbm-210219","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T13:13:46Z","timestamp":1631279626000},"page":"1-16","source":"Crossref","is-referenced-by-count":9,"title":["Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis"],"prefix":"10.1177","volume":"33","author":[{"given":"Lud\u011bk","family":"Z\u00e1vesk\u00fd","sequence":"first","affiliation":[{"name":"Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague and General University Hospital in Prague, Prague, Czech Republic"},{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Jand\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Masaryk University and University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edt","family":"Weinberger","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Masaryk University and University Hospital Brno, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Hanz\u00edkov\u00e1","sequence":"additional","affiliation":[{"name":"Faculty Transfusion Center, General University Hospital, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Slana\u0159","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milada","family":"Kohoutov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Prague and General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/CBM-210219_ref1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.3233\/CBM-210219_ref2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecologic Oncology"},{"key":"10.3233\/CBM-210219_ref3","doi-asserted-by":"crossref","first-page":"23862","DOI":"10.18632\/oncotarget.13317","article-title":"Clinical outcome and prognostic factors of patients with earlystage epithelial ovarian cancer","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210219_ref4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/gyno.1996.0106","article-title":"The prognostic implication of ascites in advanced-stage ovarian cancer","volume":"61","author":"Puls","year":"1996","journal-title":"Gynecologic Oncology"},{"key":"10.3233\/CBM-210219_ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14682"},{"key":"10.3233\/CBM-210219_ref6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Frontiers in Oncology"},{"key":"10.3233\/CBM-210219_ref7","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1074\/mcp.M114.041194","article-title":"Proteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communication","volume":"13","author":"Shender","year":"2014","journal-title":"Molecular and Cellular Proteomics"},{"issue":"577","key":"10.3233\/CBM-210219_ref8","doi-asserted-by":"crossref","first-page":"eabb0192","DOI":"10.1126\/scitranslmed.abb0192","article-title":"Characterization ofascites- and x tumor-infiltratinggamma delta T cells reveals distinct repertoires and a beneficial role in ovarian cancer","volume":"13","author":"Foord","year":"2021","journal-title":"Science Translational Medicine"},{"key":"10.3233\/CBM-210219_ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: New avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nature Reviews Cancer"},{"key":"10.3233\/CBM-210219_ref10","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.4161\/cc.29951","article-title":"The bright side of ascites in ovarian cancer","volume":"13","author":"Cohen","year":"2014","journal-title":"Cell Cycle"},{"key":"10.3233\/CBM-210219_ref11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7150\/thno.37423","article-title":"WNT signaling inducing activity in ascites predicts poor outcome in ovarian cancer","volume":"10","author":"Kotrbova","year":"2020","journal-title":"Theranostics"},{"key":"10.3233\/CBM-210219_ref12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Molecular Medicine"},{"key":"10.3233\/CBM-210219_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22020790","article-title":"Biologically active tissue factor-bearing larger ectosome-like extracellular vesicles in malignant effusions from ovarian cancer patients: Correlation with incidence of thrombosis","volume":"22","author":"Steidel","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.3233\/CBM-210219_ref14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-016-1420-5","article-title":"miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance","volume":"94","author":"Mutlu","year":"2016","journal-title":"Journal of Molecular Medicine"},{"key":"10.3233\/CBM-210219_ref15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.biocel.2010.01.014","article-title":"MicroRNAs in ovarian cancer biology and therapy resistance","volume":"42","author":"van Jaarsveld","year":"2010","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.3233\/CBM-210219_ref16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1111\/j.1582-4934.2010.01148.x","article-title":"miRNA profiling along tumour progression in ovarian carcinoma","volume":"15","author":"Vaksman","year":"2011","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.3233\/CBM-210219_ref17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/IGC.0b013e31828c166d","article-title":"Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient","volume":"23","author":"Chung","year":"2013","journal-title":"International Journal of Gynecological Cancer"},{"key":"10.3233\/CBM-210219_ref18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncy.21442","article-title":"Programmed cell death 4 and microRNA 21 inverse expression is maintained in cells and exosomes from ovarian serous carcinoma effusions","volume":"122","author":"Cappellesso","year":"2014","journal-title":"Cancer Cytopathology"},{"key":"10.3233\/CBM-210219_ref19","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.3233\/CBM-210219_ref20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.humpath.2016.03.010","article-title":"MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma","volume":"54","author":"Nymoen","year":"2016","journal-title":"Human Pathology"},{"key":"10.3233\/CBM-210219_ref21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/1933719118776808","article-title":"Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer","volume":"26","author":"Zavesky","year":"2019","journal-title":"Reproductive Sciences"},{"key":"10.3233\/CBM-210219_ref22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/07357907.2019.1663208","article-title":"Ovarian cancer: differentially expressed micrornas in tumor tissue and cell-free ascitic fluid as potential novel biomarkers","volume":"37","author":"Zavesky","year":"2019","journal-title":"Cancer Investigation"},{"key":"10.3233\/CBM-210219_ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228762","article-title":"Role of extracellular vesicles in epithelial ovarian cancer: A systematic review","volume":"21","author":"Lucidi","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.3233\/CBM-210219_ref24","doi-asserted-by":"crossref","unstructured":"C.M. Yamamoto, M.L. Oakes, T. Murakami et al., Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers, Journal of Ovarian Research 11 (2018), Article Number: 20.","DOI":"10.1186\/s13048-018-0391-2"},{"key":"10.3233\/CBM-210219_ref25","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA expression profiles in serous ovarian carcinoma","volume":"14","author":"Nam","year":"2008","journal-title":"Clinical Cancer Research"},{"issue":"2","key":"10.3233\/CBM-210219_ref26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistence by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-210219_ref27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ijc.28371","article-title":"Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma","volume":"134","author":"Tang","year":"2014","journal-title":"International Journal of Cancer"},{"key":"10.3233\/CBM-210219_ref28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/cas.14708","article-title":"Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer","volume":"112","author":"Kuang","year":"2021","journal-title":"Cancer Science"},{"key":"10.3233\/CBM-210219_ref29","doi-asserted-by":"crossref","unstructured":"H. Li, F. Zheng, Y. Bo et al., MicroRNA let-7b inhibits cell proliferation via upregulation of p21 in hepatocellular carcinoma, Cell and Bioscience 10(1) (2020), Article Number: 83.","DOI":"10.1186\/s13578-020-00443-x"},{"key":"10.3233\/CBM-210219_ref30","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.sjbs.2018.03.004","article-title":"Let-7b contributes to hepatocellular cancer progression through Wnt\/+\u2013catenin signaling","volume":"25","author":"Wang","year":"2018","journal-title":"Saudi Journal of Biological Sciences"},{"key":"10.3233\/CBM-210219_ref31","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41417-018-0048-8","article-title":"Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB","volume":"25","author":"Han","year":"2018","journal-title":"Cancer Gene Therapy"},{"key":"10.3233\/CBM-210219_ref32","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12743"},{"key":"10.3233\/CBM-210219_ref33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/07357907.2019.1709482","article-title":"Hsa-let-7b Suppresses Cell Proliferation by Targeting UHRF1 in Melanoma","volume":"38","author":"Lu","year":"2020","journal-title":"Cancer Investigation"},{"key":"10.3233\/CBM-210219_ref34","first-page":"368","article-title":"MiR-26a inhibits ovarian cancer cell proliferation, migration and invasion by targeting TCF12","volume":"43","author":"Gao","year":"2020","journal-title":"Oncology Reports"},{"key":"10.3233\/CBM-210219_ref35","first-page":"1037","article-title":"miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression","volume":"8","author":"Sun","year":"2016","journal-title":"American Journal of Translational Research"},{"key":"10.3233\/CBM-210219_ref36","doi-asserted-by":"crossref","unstructured":"W. Shen, M. Song, J. Liu et al., MiR-26a promotes ovarian cancer proliferation and tumorigenesis, PLoS ONE 9(1) (2014), Article Number: e86871.","DOI":"10.1371\/journal.pone.0086871"},{"key":"10.3233\/CBM-210219_ref37","doi-asserted-by":"crossref","unstructured":"Z. Wei, K. Chang, C. Fan and Y. Zhang, MiR-26a\/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1, Cancer Cell International 20(1) (2020), Article Number: 82.","DOI":"10.1186\/s12935-020-1166-6"},{"key":"10.3233\/CBM-210219_ref38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.21037\/tcr.2020.02.36","article-title":"MiRNA-26a blocks interleukin-2-mediated migration and proliferation of non-small cell lung cancer cells via vascular cell adhesion molecule-1","volume":"9","author":"Li","year":"2020","journal-title":"Translational Cancer Research"},{"key":"10.3233\/CBM-210219_ref39","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2147\/CMAR.S237752","article-title":"Effect and mechanism of mir-26a-5p on proliferation and apoptosis of hepatocellular carcinoma cells","volume":"12","author":"Zhu","year":"2020","journal-title":"Cancer Management and Research"},{"key":"10.3233\/CBM-210219_ref40","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s41374-019-0270-5","article-title":"miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2","volume":"99","author":"Zhao","year":"2019","journal-title":"Laboratory Investigation"},{"key":"10.3233\/CBM-210219_ref41","doi-asserted-by":"crossref","unstructured":"Y.L. Yuan, H. Yu, S.M. Mu et al., MiR-26a-5p Inhibits Cell Proliferation and Enhances Doxorubicin Sensitivity in HCC Cells via Targeting AURKA, Technology in Cancer Research & Treatment 18 (2019), Article Number: 1533033819851833.","DOI":"10.1177\/1533033819851833"},{"key":"10.3233\/CBM-210219_ref42","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.biopha.2018.02.118","article-title":"The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells","volume":"101","author":"Ma","year":"2018","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"10.3233\/CBM-210219_ref43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1089\/cbr.2018.2664","article-title":"Targeted regulation of mir-26a on pten to affect proliferation and apoptosis of prostate cancer cells","volume":"34","author":"Li","year":"2019","journal-title":"Cancer Biotherapy and Radiopharmaceuticals"},{"key":"10.3233\/CBM-210219_ref44","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/kjm2.12085","article-title":"MicroRNA-26a-5p inhibits breast cancer cell growth by suppressing RNF6 expression","volume":"35","author":"Huang","year":"2019","journal-title":"Kaohsiung Journal of Medical Sciences"},{"key":"10.3233\/CBM-210219_ref45","first-page":"893","article-title":"Serum miR-26a\/b expression correlates with pathological features in patients with gastric cancer","volume":"13","author":"Xi","year":"2021","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.3233\/CBM-210219_ref46","doi-asserted-by":"crossref","unstructured":"J. Coronel-Hernandez, E. Lopez-Urrutia, C. Contreras-Romero et al., Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN-AKT axis, Cancer Cell International 19 (2019), Article Number 80.","DOI":"10.1186\/s12935-019-0802-5"},{"key":"10.3233\/CBM-210219_ref47","first-page":"5893","article-title":"MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer","volume":"15","author":"Cai","year":"2018","journal-title":"Oncology Letters"},{"key":"10.3233\/CBM-210219_ref48","first-page":"11234","article-title":"miR-26a inhibits cell proliferation and induces apoptosis in human bladder cancer through regulating EZH2 bioactivity","volume":"10","author":"Zhou","year":"2017","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.3233\/CBM-210219_ref49","first-page":"4803","article-title":"MiR-26a suppresses the growth and metastasis via targeting matrix metalloproteinase 14 in pancreatic ductal adenocarcinoma","volume":"9","author":"Zhong","year":"2016","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.3233\/CBM-210219_ref50","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3892\/mmr.2014.2335","article-title":"MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1","volume":"10","author":"Dong","year":"2014","journal-title":"Molecular Medicine Reports"},{"key":"10.3233\/CBM-210219_ref51","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/jid.2012.400","article-title":"MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)","volume":"133","author":"Reuland","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"key":"10.3233\/CBM-210219_ref52","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/ol.2013.1173","article-title":"miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2","volume":"5","author":"Yu","year":"2013","journal-title":"Oncology Letters"},{"key":"10.3233\/CBM-210219_ref53","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-210219_ref54","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bbrc.2013.10.053","article-title":"MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1","volume":"441","author":"Wu","year":"2013","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.3233\/CBM-210219_ref55","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ijc.28774","article-title":"MiR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6","volume":"135","author":"Zhu","year":"2014","journal-title":"International Journal of Cancer"},{"key":"10.3233\/CBM-210219_ref56","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7785\/tcrt.2012.500367","article-title":"MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer","volume":"13","author":"Zhang","year":"2014","journal-title":"Technology in Cancer Research and Treatment"},{"key":"10.3233\/CBM-210219_ref57","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.18632\/oncotarget.2522","article-title":"miR-145 inhibits tumor growth and metastasis by targeting metadherin in high-grade serous ovarian carcinoma","volume":"5","author":"Dong","year":"2014","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210219_ref58","doi-asserted-by":"crossref","unstructured":"T.H. Kim, J.Y. Song, H. Park et al., MiR-145,targetinghigh-mobilitygroupA2,isapowerfulpredictorofpatientoutcomeinovariancarcinoma, Cancer Letters 356 (2015), 937\u201345.","DOI":"10.1016\/j.canlet.2014.11.011"},{"key":"10.3233\/CBM-210219_ref59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ygyno.2015.10.008","article-title":"MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer","volume":"139","author":"Chen","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.3233\/CBM-210219_ref60","first-page":"3443","article-title":"Mechanisms of miR-145 regulating invasion and metastasis of ovarian carcinoma","volume":"9","author":"Wang","year":"2017","journal-title":"American Journal of Translational Research"},{"key":"10.3233\/CBM-210219_ref61","first-page":"3575","article-title":"MiR-145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3","volume":"49","author":"Hua","year":"2019","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.3233\/CBM-210219_ref62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13048-020-00656-1","article-title":"MicroRNA-145-5p regulates the proliferation of epithelial ovarian cancer cells via targeting SMAD4","volume":"13","author":"Zhou","year":"2020","journal-title":"Journal of Ovarian Research"},{"key":"10.3233\/CBM-210219_ref63","doi-asserted-by":"crossref","unstructured":"J. Li, L. Wu, M. Pei and Y. Zhang, YTHDF2, a protein repressed by miR-145, regulates proliferation, apoptosis, and migration in ovarian cancer cells, Journal of Ovarian Research 13(1) (2020), Article Number: 111.","DOI":"10.1186\/s13048-020-00717-5"},{"key":"10.3233\/CBM-210219_ref64","first-page":"655","article-title":"Identification of microRNAs and target genes involved in serous ovarian carcinoma and their influence on survival","volume":"35","author":"Wang","year":"2014","journal-title":"European Journal of Gynaecological Oncology"},{"issue":"2","key":"10.3233\/CBM-210219_ref65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.canlet.2014.11.011","article-title":"miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma","volume":"356","author":"Kim","year":"2015","journal-title":"Cancer Letters"},{"key":"10.3233\/CBM-210219_ref66","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1007\/s13277-015-3191-y","article-title":"Serum microRNA-145 as a novel biomarker in human ovarian cancer","volume":"36","author":"Liang","year":"2015","journal-title":"Tumor Biology"},{"key":"10.3233\/CBM-210219_ref67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjms.2019.07.005","article-title":"The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer","volume":"358","author":"Wang","year":"2019","journal-title":"American Journal of the Medical Sciences"},{"key":"10.3233\/CBM-210219_ref68","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"Journal of Cancer"},{"key":"10.3233\/CBM-210219_ref69","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/15384047.2015.1046024","article-title":"Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1","volume":"16","author":"Ye","year":"2015","journal-title":"Cancer Biology and Therapy"},{"key":"10.3233\/CBM-210219_ref70","first-page":"3106","article-title":"miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition","volume":"8","author":"Zhao","year":"2016","journal-title":"American Journal of Translational Research"},{"key":"10.3233\/CBM-210219_ref71","doi-asserted-by":"crossref","first-page":"7599","DOI":"10.18632\/oncotarget.2281","article-title":"MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer","volume":"5","author":"Khan","year":"2014","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210219_ref72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cbin.11486","article-title":"The negative feedback between miR-143 and DNMT3A regulates cisplatin resistance in ovarian cancer","volume":"45","author":"Han","year":"2021","journal-title":"Cell Biology International"},{"key":"10.3233\/CBM-210219_ref73","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4149\/neo_2020_190617N515","article-title":"Lncrna CDKN2B-AS1 promotes the progression of ovarian cancer by MiR-143-3p\/SMAD3 axis and predicts a poor prognosis","volume":"67","author":"Xu","year":"2020","journal-title":"Neoplasma"},{"key":"10.3233\/CBM-210219_ref74","first-page":"1375","article-title":"Long non-coding RNA MCM3AP-AS1 drives ovarian cancer progression via the microRNA-143-3p\/TAK1 axis","volume":"44","author":"Wen","year":"2020","journal-title":"Oncology Reports"},{"key":"10.3233\/CBM-210219_ref75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtn.2019.05.007","article-title":"lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143\/FOSL2-Signaling Pathway in Ovarian Cancer","volume":"17","author":"Li","year":"2019","journal-title":"Molecular Therapy \u2013 Nucleic Acids"},{"key":"10.3233\/CBM-210219_ref76","first-page":"2644","article-title":"MALAT1 affects ovarian cancer cell behavior and patient survival","volume":"39","author":"Lin","year":"2018","journal-title":"Oncology Reports"},{"key":"10.3233\/CBM-210219_ref77","first-page":"267","article-title":"Transforming growth factor-beta\/miR-143-3p\/cystatin B axis is a therapeutic target in human ovarian cancer","volume":"55","author":"Guan","year":"2019","journal-title":"International Journal of Oncology"},{"key":"10.3233\/CBM-210219_ref78","first-page":"866","article-title":"MiR-143-3p suppresses the progression of ovarian cancer","volume":"10","author":"Shi","year":"2018","journal-title":"American Journal of Translational Research"},{"key":"10.3233\/CBM-210219_ref79","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3892\/or.2016.5148","article-title":"Dysregulation of micro-143-3p and BALBP1 contributes to the pathogenesis of the development of ovarian carcinoma","volume":"36","author":"Zhang","year":"2016","journal-title":"Oncology Reports"},{"key":"10.3233\/CBM-210219_ref80","first-page":"2716","article-title":"MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer","volume":"8","author":"Wang","year":"2016","journal-title":"American Journal of Translational Research"},{"key":"10.3233\/CBM-210219_ref81","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cas.13910","article-title":"MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3","volume":"110","author":"Guo","year":"2019","journal-title":"Cancer Science"},{"key":"10.3233\/CBM-210219_ref82","first-page":"20","article-title":"Involvement of dual strands of miR-143 (miR-143-5p and miR-143-3p) and their target oncogenes in the molecular pathogenesis of lung adenocarcinoma","author":"Sanada","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"key":"10.3233\/CBM-210219_ref83","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1158\/0008-5472.CAN-10-3032","article-title":"MicroRNA-95 promotes cell proliferation and targets sorting nexin 1 in human colorectal carcinoma","volume":"71","author":"Huang","year":"2011","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-210219_ref84","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1055\/s-0034-1398564","article-title":"Glargine Promotes Human Colorectal Cancer Cell Proliferation via Upregulation of miR-95","volume":"47","author":"Qin","year":"2015","journal-title":"Hormone and Metabolic Research"},{"key":"10.3233\/CBM-210219_ref85","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1159\/000374013","article-title":"Genistein inhibits human colorectal cancer growth and suppresses MiR-95, Akt and SGK1","volume":"35","author":"Qin","year":"2015","journal-title":"Cellular Physiology and Biochemistry"},{"key":"10.3233\/CBM-210219_ref86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.gene.2016.07.012","article-title":"Calycosin induces apoptosis in colorectal cancer cells, through modulating the ER+-\/MiR-95 and IGF-1R, PI3K\/Akt signaling pathways","volume":"592","author":"Zhao","year":"2016","journal-title":"Gene"},{"key":"10.3233\/CBM-210219_ref87","doi-asserted-by":"crossref","unstructured":"X. Chen, J. Gu, Y. Wu et al., Clinical characteristics of colorectal cancer patients and anti-neoplasm activity of genistein, Biomedicine and Pharmacotherapy 124 (2020), Article Number: 109835.","DOI":"10.1016\/j.biopha.2020.109835"},{"key":"10.3233\/CBM-210219_ref88","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/jcp.29010","article-title":"microRNA-95 knockdown inhibits epithelial-mesenchymal transition and cancer stem cell phenotype in gastric cancer cells through MAPK pathway by upregulating DUSP5","volume":"235","author":"Du","year":"2020","journal-title":"Journal of Cellular Physiology"},{"key":"10.3233\/CBM-210219_ref89","first-page":"1002","article-title":"MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt\/+\u2013catenin pathway","volume":"23","author":"Xi","year":"2019","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.3233\/CBM-210219_ref90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bj.2019.03.006","article-title":"MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF","volume":"43","author":"Hong","year":"2020","journal-title":"Biomedical Journal"},{"key":"10.3233\/CBM-210219_ref91","doi-asserted-by":"crossref","unstructured":"B. Elgaaen, O.K. Olstad, K.B.F. Haug et al., Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker, BMC Cancer 14 (2014), Article Number: 80.","DOI":"10.1186\/1471-2407-14-80"},{"key":"10.3233\/CBM-210219_ref92","doi-asserted-by":"crossref","unstructured":"L. Wang, M.J. Zhu, A.M. Ren et al., A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer, PLoS ONE 9(5) (2014), Article Number: e96472.","DOI":"10.1371\/journal.pone.0096472"},{"key":"10.3233\/CBM-210219_ref93","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/gcc.22387","article-title":"Molecular bases of aberrant miR-182 expression in ovarian cancer","volume":"55","author":"Marzec-Kotarska","year":"2016","journal-title":"Genes Chromosomes and Cancer"},{"key":"10.3233\/CBM-210219_ref94","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ijbiomac.2018.09.179","article-title":"LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p\/FOXF2 signaling pathway","volume":"120","author":"Wang","year":"2018","journal-title":"International Journal of Biological Macromolecules"},{"key":"10.3233\/CBM-210219_ref95","doi-asserted-by":"crossref","unstructured":"N. Wang, Q.X. Cao, J. Tian et al., Circular RNA MTO1 Inhibits the Proliferation and Invasion of Ovarian Cancer Cells Through the miR-182-5p\/KLF15 Axis, Cell Transplantation 29 (2020), Article Number: 0963689720943613.","DOI":"10.1177\/0963689720943613"},{"key":"10.3233\/CBM-210219_ref96","first-page":"2279","article-title":"miR-182-5p functions as a tumor suppressor to sensitize human ovarian cancer cells to cisplatin through direct targeting the cyclin dependent kinase 6 (CDK6)","volume":"25","author":"Duan","year":"2020","journal-title":"Journal of BUON"},{"key":"10.3233\/CBM-210219_ref97","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.canlet.2020.04.021","article-title":"MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C","volume":"488","author":"Yan","year":"2020","journal-title":"Cancer Letters"},{"key":"10.3233\/CBM-210219_ref98","doi-asserted-by":"crossref","unstructured":"L. Gao, S.B. Yan, J. Yang et al., MiR-182-5p and its target HOXA9 in non-small cell lung cancer: A clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip, BMC Medical Genomics 13(1) (2020), Article Number: 3.","DOI":"10.1186\/s12920-019-0648-7"},{"key":"10.3233\/CBM-210219_ref99","doi-asserted-by":"crossref","unstructured":"N. Dahiya, C.A. Sherman-Baust, T.L. Wang et al., MicroRNA expression and identification of putative miRNA targets in ovarian cancer, PLoS ONE 3(6) (2008), Article Number: e2436.","DOI":"10.1371\/journal.pone.0002436"},{"key":"10.3233\/CBM-210219_ref100","first-page":"1453","article-title":"mir-200b and mir-200c co-contribute to the cisplatin sensitivity of ovarian cancer cells by targeting DNA methyltransferases","volume":"17","author":"Liu","year":"2019","journal-title":"Oncology Letters"},{"key":"10.3233\/CBM-210219_ref101","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.18632\/oncotarget.3052","article-title":"The microRNA-200 family: Small molecules with novel roles in cancer development, progression and therapy","volume":"6","author":"Humphries","year":"2015","journal-title":"Oncotarget"},{"issue":"49","key":"10.3233\/CBM-210219_ref102","doi-asserted-by":"crossref","first-page":"81621","DOI":"10.18632\/oncotarget.13154","article-title":"miRNA-200a\/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations","volume":"7","author":"Teng","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210219_ref103","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ygyno.2009.08.009","article-title":"Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition","volume":"116","author":"Bendoraite","year":"2010","journal-title":"Gynecologic Oncology"},{"key":"10.3233\/CBM-210219_ref104","doi-asserted-by":"crossref","unstructured":"N. Jabbari, A.N. Reavis and J.F. McDonald, Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells, Journal of Ovarian Research 7 (2014), Article Number: 12.","DOI":"10.1186\/1757-2215-7-12"},{"key":"10.3233\/CBM-210219_ref105","doi-asserted-by":"crossref","unstructured":"M. Kobayashi, C. Salomon, J. Tapia et al., Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200, Journal of Translational Medicine 12 (2014), Article Number: 4","DOI":"10.1186\/1479-5876-12-4"},{"key":"10.3233\/CBM-210219_ref106","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.3233\/CBM-210219_ref107","doi-asserted-by":"crossref","unstructured":"S.K. Wyman, R.K. Parkin, P.S. Mitchell et al., Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries, PLoS ONE 4(4) (2009), Article Number: e5311.","DOI":"10.1371\/journal.pone.0005311"},{"key":"10.3233\/CBM-210219_ref108","first-page":"2392","article-title":"Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer","volume":"7","author":"Cao","year":"2014","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.3233\/CBM-210219_ref109","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mam.2019.09.005","article-title":"MiR-200 family and cancer: From a meta-analysis view","volume":"70","author":"Huang","year":"2019","journal-title":"Molecular Aspects of Medicine"},{"key":"10.3233\/CBM-210219_ref110","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1470-2045(11)70012-2","article-title":"Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: A retrospective study of two independent tumour tissue collections","volume":"12","author":"Marchini","year":"2011","journal-title":"The Lancet Oncology"},{"key":"10.3233\/CBM-210219_ref111","doi-asserted-by":"crossref","unstructured":"S. Prislei, E. Martinelli, M. Mariani et al., MiR-200c and HuR in ovarian cancer, BMC Cancer 13 (2013), Article Number: 72","DOI":"10.1186\/1471-2407-13-72"},{"key":"10.3233\/CBM-210219_ref112","doi-asserted-by":"crossref","unstructured":"M. Shi, Y. Mu, H. Zhang et al., MicroRNA-200 and microRNA-30 family as prognostic molecular signatures in ovarian cancer: A meta-analysis, Medicine (United States) 97(32) (2018), Article Number: e11505.","DOI":"10.1097\/MD.0000000000011505"},{"key":"10.3233\/CBM-210219_ref113","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1007\/s13277-015-3138-3","article-title":"MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer","volume":"36","author":"Gao","journal-title":"Tumor Biology"},{"key":"10.3233\/CBM-210219_ref114","doi-asserted-by":"crossref","unstructured":"F.F. Ibrahim, R. Jamal, S.E. Syafruddin et al., MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer, Journal of Ovarian Research 8 (2015), Article Number: 56.","DOI":"10.1186\/s13048-015-0186-7"},{"key":"10.3233\/CBM-210219_ref115","doi-asserted-by":"crossref","unstructured":"C.W.S. Kan, M.A. Hahn, G.B. Gard et al., Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer, BMC Cancer 12 (2012), Article Number: 627.","DOI":"10.1186\/1471-2407-12-627"},{"key":"10.3233\/CBM-210219_ref116","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12094-015-1303-1","article-title":"Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features","volume":"17","author":"Zuberi","year":"2015","journal-title":"Clinical and Translational Oncology"},{"key":"10.3233\/CBM-210219_ref117","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.18632\/oncotarget.7850","article-title":"Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-210219_ref118","doi-asserted-by":"crossref","unstructured":"A.R. Halvorsen, G. Kristensen, A. Embleton et al., Evaluation of prognostic and predictive significance of circulating MicroRNAs in ovarian cancer patients, Disease Markers 2017 (2017), Article Number: 3098542.","DOI":"10.1155\/2017\/3098542"},{"key":"10.3233\/CBM-210219_ref119","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-12-0463","article-title":"Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel","volume":"11","author":"Cittelly","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.3233\/CBM-210219_ref120","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.molonc.2015.04.015","article-title":"The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells","volume":"9","author":"Brozovic","year":"2015","journal-title":"Molecular Oncology"},{"key":"10.3233\/CBM-210219_ref121","first-page":"13783","article-title":"MiR-200c inhibits HOTAIR expression resulting in the decrease of chemoresistance in ovarian cancer stem cells","volume":"9","author":"Wang","year":"2016","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.3233\/CBM-210219_ref122","doi-asserted-by":"crossref","unstructured":"E. Vescarelli, G. Gerini, F. Megiorni et al., MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1, Journal of Experimental and Clinical Cancer Research 39(1) (2020), Article Number: 3.","DOI":"10.1186\/s13046-019-1490-7"},{"key":"10.3233\/CBM-210219_ref123","doi-asserted-by":"crossref","unstructured":"D. Chen, Y. Zhang, J. Wang et al., MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition, Journal of Ovarian Research 6 (2013), Article Number: 50.","DOI":"10.1186\/1757-2215-6-50"},{"key":"10.3233\/CBM-210219_ref124","doi-asserted-by":"crossref","unstructured":"Y. Huang, Y. Liu, C. Zheng and C. Shen, Investigation of cross-contamination and misidentification of 278 widely used tumor cell lines, PLoS ONE 12(1) (2017), Article Number: e0170384.","DOI":"10.1371\/journal.pone.0170384"},{"key":"10.3233\/CBM-210219_ref125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.3233\/CBM-210219_ref126","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA Spectrum in 12 Body Fluids 13","volume":"56","author":"Weber","year":"2010","journal-title":"Clinical Chemistry"},{"key":"10.3233\/CBM-210219_ref127","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1158\/0008-5472.CAN-20-0521","article-title":"Multiomic analysis of subtype evolution and heterogeneity in high-grade serous ovarian carcinoma","volume":"80","author":"Geistlinger","year":"2021","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-210219_ref128","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4149\/neo_2015_062","article-title":"New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers","volume":"62","author":"Zavesky","year":"2015","journal-title":"Neoplasma"},{"key":"10.3233\/CBM-210219_ref129","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00404-020-05477-7","article-title":"Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer","volume":"301","author":"Banys-Paluchowski","year":"2020","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.3233\/CBM-210219_ref130","doi-asserted-by":"crossref","unstructured":"A. Yokoi, J. Matsuzaki, Y. Yamamoto et al., Integrated extracellular microRNA profiling for ovarian cancer screening, Nature Communications 9(2018), Article Number: 4319.","DOI":"10.1038\/s41467-018-06434-4"},{"key":"10.3233\/CBM-210219_ref131","doi-asserted-by":"crossref","unstructured":"E. Krasniqi, A. Sacconi, D. Marinelli et al., MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study, Biomarker Research 9 (2021), Article number: 57.","DOI":"10.1186\/s40364-021-00289-6"},{"issue":"9","key":"10.3233\/CBM-210219_ref132","doi-asserted-by":"crossref","first-page":"12660","DOI":"10.18632\/aging.202940","article-title":"Identification of the miRNA signature associated with survival in patients with ovarian cancer","volume":"13","author":"Sathipati","year":"2021","journal-title":"Aging-US"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-210219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:08:25Z","timestamp":1777385305000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-210219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":132,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/cbm-210219","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,14]]}}}